Drug demand-supply guidance

In order to manage additional demand for medicines in critical care and anaesthesia during the on-going COVID-19 pandemic, the Royal College of Anaesthetists, Association of Anaesthetists, Faculty of Intensive Care Medicine, Intensive Care Society and UK Clinical Pharmacy Association have worked closely with the Chief Pharmaceutical Officer at NHS England to publish the following clinical guidance.

Departments of anaesthesia and intensive care are asked to collaborate with each other and with critical care pharmacists in order to ensure drugs are prioritised appropriately across the two areas. This will allow us to keep the service safe and effective for our patients during times of high demand. 

Please also see a set of patient FAQs on this subject.

For archived guidance, please click here.